"A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen monitoring technology. Reuters reports that the jury found that the Apple Watch's workout mode and heart rate notification features violated Masimo's patent. "This is a significant win in our ongoing efforts to protect our innovations and intellectual property, which is crucial to our ability to develop technology that benefits patients," Masimo said in a statement."
"An Apple spokesperson told Reuters that the company plans to appeal the verdict, adding, "The single patent in this case expired in 2022, and is specific to historic patient monitoring technology from decades ago." The U.S. International Trade Commission sided by Masimo in 2023, banning Apple from importing Apple Watches with blood oxygen monitoring features - which is why Apple Watches have not supported blood oxygen monitoring in recent years. Then Apple announced in August of this year that it's introducing a new version of the feature designed to circumvent the ban, with blood oxygen readings measured and calculated on the user's paired iPhone, rather than the Apple Watch itself."
A federal jury in California ordered Apple to pay Masimo $634 million for infringing a patent on pulse oximetry used in Apple Watch features. The jury found that the Apple Watch's workout mode and heart rate notification features violated Masimo's patent. Masimo described the verdict as a significant win for protecting innovations and intellectual property that benefit patients. Apple said it will appeal and noted the single patent expired in 2022 and related to historic patient monitoring technology. The U.S. International Trade Commission previously banned imports of Apple Watches with blood oxygen monitoring, and Apple introduced an iPhone-based implementation to address that ban. Ongoing related legal actions continue between the parties.
Read at TechCrunch
Unable to calculate read time
Collection
[
|
...
]